Astellas, Nissan, Kobe Steel, Tepco: Japan Equity Preview
This article is for subscribers only.
The following companies may have unusual price changes in Japanese trading today. Stock symbols are in parentheses, and share prices are as of the latest close. The information in each item was released after markets shut unless stated otherwise.
Astellas Pharma Inc. (4503 JT): Japan’s second-biggest drug manufacturer will pay $76 million to buy out partner Maxygen Inc. and make Perseid Therapeutics LLC a wholly owned subsidiary. The stock was little changed at 2,893 yen.